Literature DB >> 911231

Neuroparalytic accidents of antirabies vaccination with suckling mouse brain vaccine. Clinical and pathologic study of 21 cases.

G Toro, I Vergara, G Román.   

Abstract

Twenty-one cases of neuroparalytic accidents of rabies vaccination (with suckling mouse brain vaccine), 11 of them fatal, were observed, occurring predominantly in men; the mean age of the patients was 29 years. On the average, 13 doses of the vaccine were used. Only three patients received less than seven doses. The mean latent period was 14 days (range, 4 to 24 days). In 16 patients (76%), a Guillain-Barré syndrome occurred that was moderate in three, severe in seven, and fatal in six. Pathologically, this was shown to be a typical polyradiculoneuritis. Five patients had fatal involvement of the central nervous system. Three had an acute disseminated perivenous leukoencephalopathy, with concurrent rabies encephalitis in one case. One patient had a perivenous myeloradiculopathy and one a chronic encephalomyelopathy of six years' duration with demyelinating plaques in the periventricular white matter, cerebellum, and spinal cord. Since the reduction of postexposure rabies vaccination to seven doses, no new cases have been observed in Colombia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911231     DOI: 10.1001/archneur.1977.00500230064011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

Review 1.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

Review 2.  Pathogenesis of multiple sclerosis. A critical reappraisal.

Authors:  C M Poser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 3.  Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review.

Authors:  Vahid Reza Ostovan; Mohammad Ali Sahraian; Neda Karazhian; Mahtab Rostamihosseinkhani; Marzieh Salimi; Hoda Marbooti
Journal:  Mult Scler Relat Disord       Date:  2022-07-06       Impact factor: 4.808

Review 4.  Guillain-Barré syndrome in Colombia: where do we stand now?

Authors:  María P Mahecha; Ernesto Ojeda; Daniel A Vega; Juan C Sarmiento-Monroy; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).

Authors:  Gustavo C Román; Fernando Gracia; Antonio Torres; Alexis Palacios; Karla Gracia; Diógenes Harris
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 6.  Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.

Authors:  Haruki Koike; Atsuro Chiba; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2021-06-12

Review 7.  Emerging infectious diseases, vaccines and Guillain-Barré syndrome.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Clin Exp Neuroimmunol       Date:  2021-05-17

Review 8.  The pathogenesis of multiple sclerosis. Additional considerations.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

9.  Dorsal root ganglia may be reservoirs of viral infection in multiple sclerosis.

Authors:  D A Nelson
Journal:  Med Hypotheses       Date:  1993-05       Impact factor: 1.538

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.